Antibodies that summon white blood cells may play an important role in protecting infants from congenital infection with human cytomegalovirus, according to a study led by an investigator at Weill Cornell Medicine and NewYork-Presbyterian.
Weill Cornell Medicine and Columbia University have been awarded a five-year, $9.8 million grant from the National Cancer Institute to help combat cancer disparities fueled by persistent poverty.
New research from Cornell scientists is exploring how human genetics impacts functions of the gut microbiome, and is expanding awareness of the role human genetics plays in shaping the microbiome.
In 2023-2024 the Center for Teaching Innovation (CTI) awarded Innovative Teaching and Learning Grants to seven recipients. This year, two of those recipients' projects focus on building empathy into their courses to promote student learning.
Hysteroscopic sterilization, a nonincisional procedure, was found to be as effective as minimally invasive laparoscopic sterilization in preventing pregnancy, but both methods had higher-than-expected failure rates, according to a new study led by an investigator at Weill Cornell Medicine.
As consumers want fewer food preservatives and less plastic waste, Cornell scientists have created a bioderived polymer that helps salad dressings and beverages last longer in the fridge.
Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth.
In Medellin, Colombia, low-income residents who lived in close proximity to new public transit stations had increased rates of mosquito-transmitted dengue fever, according to a new study.
Weill Cornell Medicine has been awarded a $9.8 million grant from the National Institutes of Health to lead a consortium of health care institutions that are analyzing nationwide health data in an effort to unravel the complexities of long COVID.